CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Vectura Limited v. GlaxoSmithKline LLC

1:16-cv-00638

Overview

Case Number 1:16-cv-00638
Filing Date 2016-07-27
Status Terminated
Termination Date 2019-05-16
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Both

Parties

Defendant

Glaxo Group Limited NPE (University / Research)

Represented By

4 Attorneys Listed

Thomas C. Grimm

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Katherine A. Helm

Email: khelm@dechert.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

GlaxoSmithKline LLC NPE (University / Research)

Represented By

4 Attorneys Listed

Thomas C. Grimm

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Katherine A. Helm

Email: khelm@dechert.com

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Plaintiff

Vectura Limited NPE (University / Research)

Represented By

8 Attorneys Listed

Michael S. Scerbo

Email: MScerbo@venable.com

Michael P. McGraw

Email: mmcgraw@fchs.com

Joshua D. Calabro

Email: jcalabro@Venable.com

Damien N. Dombrowski

Email: ddombrowski@venable.com

Christopher P. Borello

Email: cborello@venable.com

Christine Dealy Haynes

Richards, Layton & Finger

Tel: +1 (302) 651-7508

Richards, Layton & Finger, 920 North King Street

Brendan M. O'Malley

UNDELIVERABLE EMAIL 8/14/2019

Kelly E. Farnan

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7705

Richards, Layton & Finger, PA, One Rodney Square

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 11 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (11): GB 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8303991
Method of making particles for use in a pharmaceutical composition
Filed: 2010-04-26
Issued: 2012-11-06
Active (3.4 yrs remaining)
Expires: 2030-04-26
US8435567
Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation
Filed: 2011-10-07
Issued: 2013-05-07
Active (4.9 yrs remaining)
Expires: 2031-10-07
US8956661
Method of making composite particles for use in pharmaceutical compositions and composite particles and compositions thereof
Filed: 2012-09-20
Issued: 2015-02-17
Active (5.8 yrs remaining)
Expires: 2032-09-20

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

87

Dispositive

31

Granted

5

Denied

2

Pending / Review

67

Motions by Category

Motion to Dismiss 4 Procedural / Extension Motion 18 Motion to Strike / Sanctions 18 Claim Construction / Markman Filing 20 Motion for Summary Judgment (Infringement) 11 Motion for Summary Judgment (Invalidity) 16

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Invalidity) Granted
ORDER: Plaintiff's Motion for Partial Summary Judgment (D.I. 126 ) is GRANTED, and Defendants' Motion for Summary Judgment of Invalidity (D.I. 122 ) is DENIED. ...
Entry #255 • 2019-03-18 Document →
Motion for Summary Judgment (Infringement) Denied
ORAL ORDER: The motion for summary judgment of non-infringement (D.I. 120 ) is DENIED as stated in open court at the hearing on March 4, 2019. Ordered by Judge ...
Entry #246 • 2019-03-04 Document →
Motion for Summary Judgment (Invalidity) Pending / Under Review
[SEALED] REPLY BRIEF re 126 MOTION for Partial Summary Judgment of No Invalidity by Anticipation filed by Vectura Limited. (Farnan, Kelly) (Entered: 02/19/2019)
Entry #216 • 2019-02-19 Document →
Motion for Summary Judgment (Invalidity) Pending / Under Review
NOTICE of of Withdrawal of Reply Brief in Support of GSK's Motion for Summary Judgment of Invalidity (D.I. 155 ) and Filing of Amended Reply Brief, by Glaxo Gro...
Entry #218 • 2019-02-19 Document →
Motion for Summary Judgment (Invalidity) Pending / Under Review
[SEALED] Amended REPLY BRIEF re 122 MOTION for Summary Judgment of Invalidity of U.S. Patent Nos. 8,303,991 and 8,435,567 for Failure to Satisfy the Enablement ...
Entry #220 • 2019-02-19 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
NOTICE of of Withdrawal of Reply Brief in Support of GSK's Motion for Summary Judgment of Non-Infringement (D.I. 156 ) and Filing of Amended Reply Brief, by Gla...
Entry #222 • 2019-02-19 Document →

Docket Entries

(489 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed with Jury Demand against Glaxo Group Limited, GlaxoSmithKline LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1970202.) - filed by Vectura Limited. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmb) (Entered: 07/27/2016)

Entry #1 • 2016-07-27
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmb) (Entered: 07/27/2016)

Entry #2 • 2016-07-27
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,303,991. (nmb) (Entered: 07/27/2016)

Entry #3 • 2016-07-27
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Vectura Group Investments Ltd., Corporate Parent Vectura Group plc, Corporate Parent HBM Healthcare Investments (Cayman) Ltd. for Vectura Limited filed by Vectura Limited. (nmb) (Entered: 07/27/2016)

Entry #4 • 2016-07-27
1

No Summons Issued. (nmb)

Entry #5 • 2016-07-27
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc